文献速递冠心病外科

机器人多支全内镜冠脉搭桥联合经皮冠状动脉介入的杂交血运重建中期结局

Hybrid coronary revascularization: Midterm outcomes of robotic multivessel bypass and percutaneous interventions.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-11-14

该回顾性研究纳入2013年7月至2017年9月连续308例全内镜冠脉搭桥患者中的57例接受晚期杂交冠脉血运重建者,分析中期生存与主要不良心脏事件。结果显示无30天死亡,住院时间短,左/右内乳动脉桥通畅率分别为95.2%和95.7%,3年生存率92.8%,3年无主要不良心脏事件生存率80.2%。

要点

  • 晚期杂交冠脉血运重建无30天死亡,住院时间短。
  • 左/右内乳动脉桥通畅率分别为95.2%和95.7%。
  • 3年生存率92.8%,3年无主要不良心脏事件生存率80.2%。

核心结论

  • 晚期杂交冠脉血运重建安全、创伤小、住院时间短且中期结局良好。

研究设计与样本

  • 回顾性研究,纳入2013年7月至2017年9月连续308例全内镜冠脉搭桥患者中的57例接受晚期杂交冠脉血运重建者,平均年龄65.6岁。

主要发现

  • 多支全内镜冠脉搭桥均成功完成,无中转开胸,50例(87.7%)使用双侧内乳动脉桥。
  • 平均手术时间318.4±51.0分钟,平均住院时间3.0±1.3天,无30天死亡。
  • 51例(89.4%)计划在搭桥后行经皮冠状动脉介入,靶病变仅右冠状动脉38例、仅左回旋支4例、多发病变13例;最终2例未接受介入,8处病变介入尝试未成功。
  • 左/右内乳动脉桥通畅率分别为95.2%(60/63)和95.7%(45/47),左回旋支桥通畅率95.2%(40/42),对角支桥通畅率93.3%(14/15)。
  • 3年生存率92.8%,3年无主要不良心脏事件生存率80.2%。

临床怎么用

  • 对于适合微创多支病变血运重建的患者,可考虑机器人全内镜冠脉搭桥联合经皮冠状动脉介入的晚期杂交策略。

局限性

  • 本研究为回顾性研究,样本量有限(57例),来自单中心连续队列。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The purpose of this study was to investigate the outcomes of patients undergoing advanced hybrid coronary revascularization, defined as robotic beating-heart multivessel totally endoscopic coronary artery bypass combined with percutaneous coronary intervention. METHODS: This is a retrospective study. Among 308 consecutive patients who underwent totally endoscopic coronary artery bypass, 57 who underwent advanced hybrid coronary revascularization (mean age, 65.6 years) from July 2013 to September 2017 were included. Midterm survival and freedom from major adverse cardiac events, including death, myocardial infarction, and repeat revascularization, were analyzed. RESULTS: Multivessel totally endoscopic coronary artery bypass was successfully performed without conversion to thoracotomy. Bilateral internal thoracic artery grafting was used in 50 patients (87.7%). The mean operative time was 318.4 ± 51.0 minutes. The mean length of hospital stay was 3.0 ± 1.3 days. There was no 30-day mortality. Percutaneous coronary intervention was planned after totally endoscopic coronary artery bypass in 51 patients (89.4%). The target lesions were the right coronary artery only in 38 patients, the left circumflex artery only in 4 patients, and multiple lesions in 13 patients. Eventually, 2 patients did not receive percutaneous coronary intervention. Percutaneous coronary intervention attempt was unsuccessful in 8 lesions. Patency of the left/right internal thoracic artery was 95.2% (60/63) and 95.7% (45/47), respectively. Graft patency was 95.2% (40/42) in the left circumflex artery and 93.3% (14/15) in the diagonal branch. Three-year survival was 92.8%, and 3-year freedom from major adverse cardiac events was 80.2%. CONCLUSIONS: Advanced hybrid coronary revascularization is a safe and less-invasive approach with short hospital stay and good midterm outcomes.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Kitahara H, Hirai T, McCrorey M, et al. Hybrid coronary revascularization: Midterm outcomes of robotic multivessel bypass and percutaneous interventions. J Thorac Cardiovasc Surg. 2018. PMID: 30635190. doi:10.1016/j.jtcvs.2018.08.126

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。